Law360, New York (February 17, 2012, 1:34 PM ET) -- The United States is at a critical moment for the advancement of the biomedical industry. Despite the struggling U.S. economy, American pharmaceutical, medical device and biotech companies continue to maintain a competitive advantage in the global marketplace.
Our track record of innovation includes not only breakthrough technologies that have created new therapeutic paradigms, but also a steady pace of product enhancements that, over time, have resulted in major improvements in health outcomes.
However, there are some signs that the health and growth of this industry is...
Increasing Access To Innovative Biomedical Technology
To view the full article, take a free trial now.
